SCHEMBL7424899

SCHEMBL7424899

Cc1ccc(-c2cccc(C(CNC(CC(C)C)C(=O)O)C(=O)O)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSK P43235 14/20 0.50
CTSS P25774 12/20 0.50
CTSL P07711 10/20 0.50
CTSB P07858 8/20 0.47
ALDH1A1 P00352 2/20 0.44
CYP2C19 P33261 1/20 0.44
NTSR1 P30989 1/20 0.43
PSEN1 P49768 2/20 0.43
PSEN2 P49810 2/20 0.43
APH1B Q8WW43 2/20 0.43
NCSTN Q92542 2/20 0.43
APH1A Q96BI3 2/20 0.43
PSENEN Q9NZ42 2/20 0.43
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424801 0.89 CTSS (0.46) CTSKCTSSCTSLCTSBALDH1A1
SCHEMBL7422599 0.85 GRN (0.47) CTSKCTSSCTSLCTSBALDH1A1
SCHEMBL7428422 0.83 AKR1C3 (0.45) CTSKCTSSCTSLCTSBCYP2C19
SCHEMBL7420947 0.83 CTSK (0.45) CTSKCTSSCTSLCTSB
SCHEMBL7378949 0.82 MME (0.50) CTSKCTSSALDH1A1CYP2C19
SCHEMBL7421831 0.80 NTSR1 (0.54) CTSKCTSSCTSLNTSR1
SCHEMBL7420340 0.78 MAPT (0.44) CTSKCTSSCTSLALDH1A1
SCHEMBL4039064 0.78 CTSK (0.67) CTSKCTSSCTSLCTSBPSEN1
SCHEMBL4310706 0.78 CTSK (0.67) CTSKCTSSCTSLCTSBPSEN1
SCHEMBL4309572 0.78 CTSK (0.67) CTSKCTSSCTSLCTSBPSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO claimed
WO-2002039997-A2 ACE-2 MODULATING COMPOUNDS AND USE THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-05-23 WO disclosed